Want to join the conversation?
For 2016, $LH expects the LabCorp Diagnostics revenue to grow 3.5-5.5% over 2015 pro forma revenue of $6.2Bil after the impact from approx. 50 BP of negative currency. For the Covance Drug Development segment, 2016 revenue is expected to grow 2-5% over 2015 pro forma revenue of $2.6Bil, after the impact from approx. 200 BP of negative currency.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!